Approved Hospital Formulary
Add Formweb to your mobile device
Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.
Please be sure to document all clinical activities daily.
Approved Hospital Formulary
Search results for:
levothyroxine
levothyroxine
- Formulary
- Restricted Thyquidity--> restricted to pediatrics and adults when crushing tablets is not appropriate.
- Non-formulary Miscellaneous Formulary
- Therapeutic Interchange
| Drug Name | Form | Strength | Formulary Unrestricted | Formulary Restricted | Non-Formulary | Interchange |
|---|---|---|---|---|---|---|
| Synthroid | POWDER FOR INJECTION, INJECTABLE | 200 mcg (0.2 mg), 500 mcg (0.5 mg) | ||||
| Tirosint-Sol | SOLUTION, ORAL | [all concentrations] | ||||
| Thyquidity | SOLUTION, ORAL | 100 mcg/5 mL | ||||
| Ermeza | SOLUTION, ORAL | 150 mcg/5 mL | ||||
| Euthyrox, Levo-T, Levotabs | TABLET, ORAL | 25 mcg, 50 mcg, 75 mcg, 88 mcg, 100 mcg, 112 mcg, 125 mcg | ||||
| Synthroid, Leveothroid, Levoxyl, Unithroid | TABLET, ORAL | 25 mcg, 50 mcg, 75 mcg, 88 mcg, 100 mcg, 112 mcg, 125 mcg | ||||
| Synthroid, Leveothroid, Levoxyl, Unithroid | TABLET, ORAL | 137 mcg, 150 mcg, 175 mcg, 200 mcg, 300 mcg | ||||
| Euthyrox, Levo-T, Levotabs | TABLET, ORAL | 150 mcg, 175 mcg, 200 mcg, 300 mcg |
Last updated: May. 28, 2026
- Black Box Warning: Treatment of obesity or weight loss
Synthroid is approved for sample use in HH Endocrinology and Diabetes Clinics.
Levothyroxine Solutions:
NOTE (W&C): Per pediatric endocrinology, levothyroxine tablets should be used whenever possible. Orders for levothyroxine solution should be interchanged to levothyroxine tablets, following a call to the provider.
Thyquidity - Use will be restricted to pediatric patients and adults who are not candidates for crushing the tablet formulation of levothyroxine. Thyquidity is not routinely stocked.
Ermeza & Tirosint-Sol - Discontinued by manufacturers. Automatic interchange to Thyquidity at a 1:1 ratio ONLY if tablets are unable to be used.
Reviewed: 27 Aug 19 (Tirosint-Sol), July 2023 (Ermeza & Thyquidity)
Updated: July 2023 (Tirosint-Sol), July 2025 (Solutions), May 2026 (Solutions)
Levothyroxine Oral Solution Update
Levothyroxine Oral Solution Update 2025